BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33063190)

  • 1. Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.
    Sitkin S; Pokrotnieks J
    Dig Dis Sci; 2021 Mar; 66(3):925-927. PubMed ID: 33063190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation.
    Xu M; Cen M; Shen Y; Zhu Y; Cheng F; Tang L; Hu W; Dai N
    Dig Dis Sci; 2021 Feb; 66(2):568-576. PubMed ID: 32198567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice.
    Xu M; Shen Y; Cen M; Zhu Y; Cheng F; Tang L; Zheng X; Kim JJ; Dai N; Hu W
    J Crohns Colitis; 2021 Jul; 15(7):1197-1210. PubMed ID: 33417675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
    Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
    Front Immunol; 2022; 13():974305. PubMed ID: 36211363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.
    Shah A; Macdonald GA; Morrison M; Holtmann G
    Am J Gastroenterol; 2020 Jun; 115(6):814-822. PubMed ID: 32250997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
    Van den Bossche L; Hindryckx P; Devisscher L; Devriese S; Van Welden S; Holvoet T; Vilchez-Vargas R; Vital M; Pieper DH; Vanden Bussche J; Vanhaecke L; Van de Wiele T; De Vos M; Laukens D
    Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28115375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation.
    Sinha SR; Haileselassie Y; Nguyen LP; Tropini C; Wang M; Becker LS; Sim D; Jarr K; Spear ET; Singh G; Namkoong H; Bittinger K; Fischbach MA; Sonnenburg JL; Habtezion A
    Cell Host Microbe; 2020 Apr; 27(4):659-670.e5. PubMed ID: 32101703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.
    Duboc H; Rajca S; Rainteau D; Benarous D; Maubert MA; Quervain E; Thomas G; Barbu V; Humbert L; Despras G; Bridonneau C; Dumetz F; Grill JP; Masliah J; Beaugerie L; Cosnes J; Chazouillères O; Poupon R; Wolf C; Mallet JM; Langella P; Trugnan G; Sokol H; Seksik P
    Gut; 2013 Apr; 62(4):531-9. PubMed ID: 22993202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota.
    Jin D; Huang K; Xu M; Hua H; Ye F; Yan J; Zhang G; Wang Y
    Gut Microbes; 2022; 14(1):2120744. PubMed ID: 36067404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective humoral immunity disrupts bile acid homeostasis which promotes inflammatory disease of the small bowel.
    Mohammed AD; Mohammed Z; Roland MM; Chatzistamou I; Jolly A; Schoettmer LM; Arroyo M; Kakar K; Tian Y; Patterson A; Nagarkatti M; Nagarkatti P; Kubinak JL
    Nat Commun; 2022 Jan; 13(1):525. PubMed ID: 35082296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis.
    Pan Y; Zhang H; Li M; He T; Guo S; Zhu L; Tan J; Wang B
    Gut Microbes; 2024; 16(1):2356284. PubMed ID: 38769683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acid toxicity in Paneth cells contributes to gut dysbiosis induced by high-fat feeding.
    Zhou H; Zhou SY; Gillilland M; Li JY; Lee A; Gao J; Zhang G; Xu X; Owyang C
    JCI Insight; 2020 Oct; 5(20):. PubMed ID: 33055426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in Bile Acid Metabolism Associated With Inflammatory Bowel Disease.
    Li N; Zhan S; Tian Z; Liu C; Xie Z; Zhang S; Chen M; Zeng Z; Zhuang X
    Inflamm Bowel Dis; 2021 Aug; 27(9):1525-1540. PubMed ID: 33399195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
    Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
    Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total alkaloids of Sophora alopecuroides L. ameliorated murine colitis by regulating bile acid metabolism and gut microbiota.
    Jia YQ; Yuan ZW; Zhang XS; Dong JQ; Liu XN; Peng XT; Yao WL; Ji P; Wei YM; Hua YL
    J Ethnopharmacol; 2020 Jun; 255():112775. PubMed ID: 32205259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention.
    Jones ML; Martoni CJ; Ganopolsky JG; Labbé A; Prakash S
    Expert Opin Biol Ther; 2014 Apr; 14(4):467-82. PubMed ID: 24479734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease.
    Thomas JP; Modos D; Rushbrook SM; Powell N; Korcsmaros T
    Front Immunol; 2022; 13():829525. PubMed ID: 35185922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside.
    Yang M; Gu Y; Li L; Liu T; Song X; Sun Y; Cao X; Wang B; Jiang K; Cao H
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 12α-Hydroxylated bile acid induces hepatic steatosis with dysbiosis in rats.
    Lee JY; Shimizu H; Hagio M; Fukiya S; Watanabe M; Tanaka Y; Joe GH; Iwaya H; Yoshitsugu R; Kikuchi K; Tsuji M; Baba N; Nose T; Tada K; Hanai T; Hori S; Takeuchi A; Furukawa Y; Shirouchi B; Sato M; Ooka T; Ogura Y; Hayashi T; Yokota A; Ishizuka S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158811. PubMed ID: 32896622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.